Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of selective GABA A α5 negative allosteric modulators for the treatment of central nervous system conditions

Use of selective GABA A α5 negative allosteric modulators for the treatment of central nervous system conditions

US Patent 8835425 · Granted Sep 16, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzodiazepine derivatives as GABA A gamma 1 PAM2025
Benzodiazepine derivatives as GABA a GAMMA1 PAM2025
Isoxazolyl ether derivatives as GABAA α5 PAM2023
Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 posit2023
Isoxazolyl ether derivatives as GABAA α5 PAM2021
Isoxazolyl ether derivatives as GABAA α5 PAM2021
Isoxazolo-pyridine derivatives2015
Solid forms2015
Isoxazolo-pyridine derivatives2014
Isoxazolo-pyridine derivatives2014
Isoxazolo-pyridine derivatives2014
Solid forms2014